ArticleJournal of patient-reported outcomes2026
Development of the Pediatric Type 2 Diabetes Impact Measure (P-TIM).
Article in Journal of patient-reported outcomes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPrevalence of type 2 diabetes (T2D) in children is increasing, and new non-insulin medications are being introduced and evaluated for use in this population. Existing patient-reported outcome (PRO) measures may contain items that are not relevant or sensitive to differences in patients receiving these newer treatments. This qualitative study was designed to explore the impact of T2D in children and to support the development of a questionnaire to assess the impact of pediatric T2D and its treatment. METHODOLOGY: Qualitative concept elicitation interviews were conducted with children with T2D and their caregivers to identify the impact of T2D and its treatment. Results were used to inform the development of a child-reported questionnaire assessing the impact of pediatric T2D. Qualitative interviews were conducted with children with T2D to evaluate the draft questionnaire.
resultsThe concept elicitation interviews were conducted with 13 children with T2D (mean age = 14.2 years; range = 10-17 years; 61.5% male) and their caregivers (mean age = 44.5 years; 76.9% female). Respondents reported broad areas of impact, including eating, emotional functioning, school, family relationships, activities, and social life. Patients also reported opinions on their treatment, including ease of use, blood glucose control, and weight control. A new PRO measure, the Pediatric Type 2 Diabetes Impact Measure (P-TIM), was developed based on these findings. The questionnaire was refined based on qualitative interviews with 10 children with T2D (mean age = 15.0 years; range = 10-17 years; 50% female). Results suggest that the final instrument is clear, comprehensive, and relevant to patients.
conclusionsResults support the content validity of the P-TIM, which was designed to assess the impact of T2D and its treatment, including concepts that are relevant to newer medications (e.g., weight control). The P-TIM may be useful for evaluating the impact of treatment on children and adolescents with T2D.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.